(Q45966276)

PubMed publication ID

24124874

18 December 2017

http://europepmc.org/abstract/MED/24124874

title

Cancer vaccines: 21st century approaches to harnessing an ancient modality to fight cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6326573&resulttype=core&format=json

13 May 2020

1

Jay A Berzofsky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6326573&resulttype=core&format=json

13 May 2020

author name string

Lauren V Wood

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6326573&resulttype=core&format=json

13 May 2020

Masaki Terabe

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6326573&resulttype=core&format=json

13 May 2020

publication date

1 October 2013

1 reference

PubMed publication ID

24124874

18 December 2017

http://europepmc.org/abstract/MED/24124874

published in

Expert Review of Vaccines

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6326573&resulttype=core&format=json

13 May 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6326573&resulttype=core&format=json

13 May 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6326573&resulttype=core&format=json

13 May 2020

page(s)

1115-1118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6326573&resulttype=core&format=json

The three Es of cancer immunoediting

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

A push-pull vaccine strategy using Toll-like receptor ligands, IL-15, and blockade of negative regulation to improve the quality and quantity of T cell immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Strategies to use immune modulators in therapeutic vaccines against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Strategies for designing and optimizing new generation vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Selective induction of high avidity CTL by altering the balance of signals from APC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

The regulatory role of Valpha14 NKT cells in innate and acquired immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Nivolumab plus ipilimumab in advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Delicate balance among three types of T cells in concurrent regulation of tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Synergistic enhancement of CD8+ T cell-mediated tumor vaccine efficacy by an anti-transforming growth factor-beta monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

TARP: a nuclear protein expressed in prostate and breast cancer cells derived from an alternate reading frame of the T cell receptor gamma chain locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836906

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway

21 January 2018

1 reference

12 December 2020

CD1-restricted T cells and tumor immunity

1 reference

12 December 2020

Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cells

1 reference

12 December 2020

β-mannosylceramide activates type I natural killer t cells to induce tumor immunity without inducing long-term functional anergy

1 reference

12 December 2020

10.1586/14760584.2013.836906

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6326573&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6326573&resulttype=core&format=json

13 May 2020

PubMed publication ID

24124874

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6326573&resulttype=core&format=json